Oncolytics Biotech Inc.
ONC.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.72M | 10.65M | 11.08M | 14.51M | 18.16M |
| Total Receivables | 52.80K | 61.90K | 47.30K | 77.00K | 1.15M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.33M | 1.30M | 1.31M | 1.57M | 2.46M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 750.80K | 848.80K | 681.10K | 808.30K | 619.60K |
| Total Current Assets | 13.85M | 12.86M | 13.12M | 16.96M | 22.38M |
|
|
|||||
| Total Current Assets | 13.85M | 12.86M | 13.12M | 16.96M | 22.38M |
| Net Property, Plant & Equipment | 790.40K | 845.30K | 911.80K | 998.60K | 1.05M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.65M | 13.71M | 14.03M | 17.96M | 23.43M |
|
|
|||||
| Total Accounts Payable | 975.90K | 542.00K | 755.50K | 2.54M | 647.40K |
| Total Accrued Expenses | 2.90M | 2.90M | 2.58M | 2.59M | 2.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 213.40K | 201.80K | 192.50K | 185.80K | 164.40K |
| Total Finance Division Other Current Liabilities | 720.00K | 368.70K | 1.12M | 362.00K | 919.90K |
| Total Other Current Liabilities | 720.00K | 368.70K | 1.12M | 362.00K | 919.90K |
| Total Current Liabilities | 4.81M | 4.01M | 4.65M | 5.67M | 4.48M |
|
|
|||||
| Total Current Liabilities | 4.81M | 4.01M | 4.65M | 5.67M | 4.48M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 437.70K | 494.00K | 547.00K | 601.80K | 651.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.93M | 4.68M | 4.68M | 4.98M | 4.92M |
| Total Liabilities | 10.18M | 9.19M | 9.87M | 11.26M | 10.05M |
|
|
|||||
| Common Stock & APIC | 363.63M | 340.86M | 335.50M | 353.90M | 349.06M |
| Retained Earnings | -359.69M | -337.01M | -332.01M | -347.68M | -336.21M |
| Treasury Stock & Other | 527.90K | 666.50K | 667.90K | 483.40K | 527.50K |
| Total Common Equity | 4.46M | 4.52M | 4.16M | 6.70M | 13.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.46M | 4.52M | 4.16M | 6.70M | 13.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.46M | 4.52M | 4.16M | 6.70M | 13.38M |
|
|
|||||